Kane Biotech Financial Overview
Kane Biotech's market cap is currently C$5.02M. The company's EPS TTM is C$-0.004; its P/E ratio is -2.46; Kane Biotech is scheduled to report earnings on November 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
